Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897) : a trial of the Eastern Cooperative Oncology Group

• HINTON S

収録刊行物

• J. Clin. Oncol.

  J. Clin. Oncol. 20 1859-1863, 2002

詳細情報

• CRID: 1573950401163786752
• NII論文ID: 30022788138
• DOI: 10.1200/jco.2002.07.158
• データソース種別:
  • CiNii Articles